Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN01577227
ISRCTN01577227
Completed
Not Applicable

Effect of mineralocorticoid receptor blockade on ischemia / reperfusion injury in renal transplant recipients: A pilot study

Mexican Council of Science and Technology (Consejo Nacional de Ciencia y Tecnología CONACyT) (Mexico)0 sites60 target enrollmentJanuary 23, 2013
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsIschemia reperfusion injuryCirculatory System

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Ischemia reperfusion injury
Sponsor
Mexican Council of Science and Technology (Consejo Nacional de Ciencia y Tecnología CONACyT) (Mexico)
Enrollment
60
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 23, 2013
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Mexican Council of Science and Technology (Consejo Nacional de Ciencia y Tecnología CONACyT) (Mexico)

Eligibility Criteria

Inclusion Criteria

  • •1\. Age of 18 years or older, male and female
  • •2\. Receipt of a live\-donor kidney

Exclusion Criteria

  • •1\. Multi\-organ transplant
  • •2\. Deceased\-donor kidney
  • •3\. Induction with thymoglobuline

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Effects of mineralocorticoid receptor agonist on intradialytic hypotension: an open-label, randomized crossover studyIntradialytic hypotensionMineralocorticoid receptor agonist
TCTR20200128004ampang hospital10
Completed
Not Applicable
The effect of a mineralocorticoid receptor antagonist eplerenone on morning home BP in drug-resistant hypertensiodrug-resistant morning hypertension
JPRN-UMIN000014186Jichi Medical University School of Medicine100
Completed
Phase 2
Effects of mineralocorticoid receptor antagonist on intradialytic hypertension: a multicenter, double-blind, randomized crossover studyIntradialytic hypertensionSpironolactoneMineralocorticoid receptor antagonist
TCTR20200604013ampang hospital49
Completed
Not Applicable
Effects of mineralocorticoid receptor antagonists on sex hormones and body composition in patients with primary aldosteronismPrimary aldosteronism
JPRN-UMIN000037657Tokyo Women's Medical University Hospital100
Active, not recruiting
Not Applicable
Effects of eplerenone on forearm blood flowhealthy volunteersTherapeutic area: Body processes [G] - Circulatory and Respiratory Physiological Phenomena [G09]
EUCTR2013-000189-12-NLniversity Medical Centre Nijmegen